Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment Taketo EzakiToshihide TanakaHikaru Sasaki Original Article Open access 15 April 2024 Pages: 61 - 72
Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma Kenta MasuiHiromi OnizukaTakashi Komori Letter to the Editor 10 April 2024 Pages: 92 - 95
Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature Manabu NatsumedaSatoshi ShibumaMakoto Oishi Rapid Short communication 10 April 2024 Pages: 85 - 91
Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis Takahiro TsuchiyaMasako IkemuraNobuhito Saito Original Article Open access 05 April 2024 Pages: 73 - 79
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy Hikaru SasakiYohei KitamuraKazunari Yoshida Review Article 02 April 2024 Pages: 43 - 49
Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for gliomas Takuma NakashimaRyo YamamotoHiromichi Suzuki Original Article 08 February 2024 Pages: 50 - 60
Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment Fumi HiguchiTakeo UzukaKeisuke Ueki Case Report 31 January 2024 Pages: 80 - 84
Correction: Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next Takashi Komori Correction 25 January 2024 Pages: 96 - 96
Pediatric diffuse glioma with EP300::BCOR fusion manifesting as low-grade epilepsy-associated neuroepithelial tumor: a case presentation Satoshi NakataYasuhito AraiSumihito Nobusawa Letter to the Editor 22 December 2023 Pages: 35 - 39
Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next Takashi Komori Editorial 19 December 2023 Pages: 1 - 3
A rare case of primary central nervous system histiocytic sarcoma harboring a novel ARHGAP45::BRAF fusion: a case report and literature review Luyi ZhangGang ZhangHangyu Shi Case Report 15 December 2023 Pages: 18 - 29
FISH analysis reveals CDKN2A and IFNA14 co-deletion is heterogeneous and is a prominent feature of glioblastoma Sofian Al ShboulShelagh BoylePaul M. Brennan Original Article 14 December 2023 Pages: 4 - 17
Primary papillary epithelial tumor of the sella: a case report of an emerging tumor type S. RimaShilpa RaoRajneesh Kacchara Case Report 13 December 2023 Pages: 30 - 34
Touch imprint cytology is useful for the intraoperative pathological diagnosis of PitNETs’ surgical margins Noriaki TanabeNaoko InoshitaShozo Yamada Original Article Open access 06 October 2023 Pages: 215 - 221
Intraventricular central neurocytoma molecularly defined as extraventricular neurocytoma: a case representing the discrepancy between clinicopathological and molecular classifications Daisuke SatoHirokazu TakamiNobuhito Saito Case Report Open access 11 September 2023 Pages: 230 - 234
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype: case series of a new entity Katja BenderJohannes KahnDavid Kaul Original Article Open access 10 August 2023 Pages: 204 - 214
Integrated analysis of multiple methods reveals characteristics of the immune microenvironment in medulloblastoma Kaiyu FanYifan WeiJian Gong Original Article 09 August 2023 Pages: 191 - 203
Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis—a case report Natsuki OgasawaraShinji YamashitaHideo Takeshima Case Report 29 July 2023 Pages: 222 - 229
A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment Naohito HashimotoTomonari SuzukiAtsushi Sasaki Original Article Open access 16 June 2023 Pages: 163 - 175
α-SMA positive vascular mural cells suppress cyst formation in hemangioblastoma Maki SakaguchiRiho NakajimaMitsutoshi Nakada Original Article 05 June 2023 Pages: 176 - 184
IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis Satoshi NakasuShoichi DeguchiYoko Nakasu Review Article 22 May 2023 Pages: 143 - 157
Lynch syndrome-associated chordoma with high tumor mutational burden and significant response to immune checkpoint inhibitors Naoki ShinojimaKazutaka OzonoAkitake Mukasa Case Report Open access 22 April 2023 Pages: 185 - 190
Immunohistochemical and ultrastructural review of six cases previously diagnosed as null cell PitNETs Naoko InoshitaToyoki YoshimotoShozo Yamada Original Article 18 April 2023 Pages: 158 - 162
Spatial metabolic heterogeneity of oligodendrogliomas at single-cell resolution Sai BatchuMichael Joseph DiazBrandon Lucke-Wold Original Article 11 April 2023 Pages: 101 - 108
Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas Yoshihiro OtaniKaishi SatomiIsao Date Review Article 01 April 2023 Pages: 56 - 65
Impact of tumor markers on diagnosis, treatment and prognosis in CNS germ cell tumors: correlations with clinical practice and histopathology Hirokazu TakamiChristopher S. GraffeoKoichi Ichimura Original Article Open access 30 March 2023 Pages: 124 - 132
Easy-to-use machine learning system for the prediction of IDH mutation and 1p/19q codeletion using MRI images of adult-type diffuse gliomas Tomohide NishikawaFumiharu OhkaRyuta Saito Original Article 29 March 2023 Pages: 85 - 92
Clinical characteristics and radiological features of glioblastoma, IDH-wildtype, grade 4 with histologically lower-grade gliomas Kazuya MotomuraYuji KibeRyuta Saito Review Article 29 March 2023 Pages: 48 - 55
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence Ryota TamuraAkio IwanamiHikaru Sasaki Original Article 09 March 2023 Pages: 109 - 123
High-grade neuroepithelial tumor with EP300::BCOR fusion and negative BCOR immunohistochemical expression: a case report Hirokazu SuginoKaishi SatomiAkihiko Yoshida Case Report 22 February 2023 Pages: 133 - 141
Liquid biomarkers in glioma Sho TamaiToshiya IchinoseMitsutoshi Nakada Review Article 17 February 2023 Pages: 66 - 77
Utility of real-time polymerase chain reaction for the assessment of CDKN2A homozygous deletion in adult-type IDH-mutant astrocytoma Yuzaburo ShimizuMario SuzukiAkihide Kondo Original Article 14 February 2023 Pages: 93 - 100
Correction: Morphologically, genetically and spatially mixed astrocytoma and oligodendroglioma; chronological acquisition of 1p/19q codeletion and CDKN2A deletion: a case report Hirokazu TakamiAkitake MukasaNobuhito Saito Correction 19 January 2023 Pages: 142 - 142
Morphologically, genetically and spatially mixed astrocytoma and oligodendroglioma; chronological acquisition of 1p/19q codeletion and CDKN2A deletion: a case report Hirokazu TakamiAkitake MukasaNobuhito Saito Case Report 26 December 2022 Pages: 26 - 34
Correlation of MTAP immunohistochemical deficiency with CDKN2A homozygous deletion and clinicopathological features in pleomorphic xanthoastrocytoma Lei LouJiajun LiYuehong Li Original Article 22 December 2022 Pages: 15 - 25
Update of the 2021 WHO classification of tumors of the central nervous system: adult diffuse gliomas Takashi Komori Editorial 20 December 2022 Pages: 1 - 3
Three-dimensional visualization of human brain tumors using the CUBIC technique Yangyang XuQi HeJie Zhang Original Article 12 November 2022 Pages: 4 - 14
PBRM1 and BAP1: novel genetic mutations in malignant transformation of craniopharyngioma—a case report Mitsuru TamuraKiyotaka YokogamiHideo Takeshima Case Report 11 November 2022 Pages: 40 - 44
An extracranial CNS presentation of the emerging “intracranial” mesenchymal tumor, FET: CREB-fusion positive Arnault Tauziède-EspariatGaëlle PierronPascale Varlet Case Report 15 September 2022 Pages: 35 - 39
Clinical application of a highly sensitive digital PCR assay to detect a small fraction of IDH1 R132H-mutant alleles in diffuse gliomas Kaishi SatomiAkihiko YoshidaKoichi Ichimura Original Article 29 July 2022 Pages: 210 - 217
Whole-genome sequencing analysis of an atypical teratoid/rhabdoid tumor in a patient with Phelan–McDermid syndrome: a case report and systematic review Haruki YamashitaYoshiki ArakawaSusumu Miyamoto Case Report 24 June 2022 Pages: 232 - 239
Aggressive nonfunctioning pituitary neuroendocrine tumors Sérgio PortovedoLeonardo Vieira NetoLeandro Miranda-Alves Review Article 20 June 2022 Pages: 183 - 199
Loss of H3K27me3 in WHO grade 3 meningioma Andrea Daniela MaierChristian Beltoft BrøchnerTiit Mathiesen Original Article 09 June 2022 Pages: 200 - 209
A primary DICER1-sarcoma with KRAS and TP53 mutations in a child with suspected ECCL Kaiyun YangJustin WangJohn Provias Case Report 06 June 2022 Pages: 225 - 231
Revisiting the definition of glioma recurrence based on a phylogenetic investigation of primary and re-emerging tumor samples: a case report Toru UmeharaHideyuki AritaHaruhiko Kishima Case Report 06 June 2022 Pages: 218 - 224
A novel YAP1-MAML2 fusion in an adult supra-tentorial ependymoma, YAP1-fused Arnault Tauziède-EspariatAurore Siegfriedthe RENOCLIP-LOC Letter to the Editor 22 May 2022 Pages: 240 - 242
Diffusely infiltrating glioma with CREBBP–BCORL1 fusion showing overexpression of not only BCORL1 but BCOR: A case report Ayako YamazakiYasuhito AraiSumihito Nobusawa Case Report 21 May 2022 Pages: 171 - 178
